alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
FOR THE PERIOD ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           4,236
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 6,067
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     16,163
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                        102,564
<ALLOWANCE>                                      1,042
<TOTAL-ASSETS>                                 137,530
<DEPOSITS>                                     121,822
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                              3,771
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           890
<OTHER-SE>                                      11,047
<TOTAL-LIABILITIES-AND-EQUITY>                 137,530
<INTEREST-LOAN>                                  3,901
<INTEREST-INVEST>                                  506
<INTEREST-OTHER>                                   268
<INTEREST-TOTAL>                                 4,676
<INTEREST-DEPOSIT>                               2,332
<INTEREST-EXPENSE>                               2,375
<INTEREST-INCOME-NET>                            2,301
<LOAN-LOSSES>                                      421
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  1,902
<INCOME-PRETAX>                                    194
<INCOME-PRE-EXTRAORDINARY>                         116
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       116
<EPS-BASIC>                                        .13
<EPS-DILUTED>                                      .13
<YIELD-ACTUAL>                                       0
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                     0
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                    0
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
Exhibit 32.2

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                       AS ADOPTED PURSUANT TO SECTION 906
                                       OF
                         THE SARBANES-OXLEY ACT OF 2002

                  In connection with the quarterly report of I-trax, Inc. (the
"Company") on Form 10-Q for the period ending March 31, 2005 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, R.
Dixon Thayer, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:

                  (1) The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

                  (2) The information contained in the Report fairly presents,
in all material respects, the financial condition and result of operations of
the Company.



/s/ David R. Bock
------------------------------
David R. Bock
Senior Vice President and
Chief Financial Officer


May 16, 2005
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel Support for Research Excellence—First Independent Research (SuRE-First) Award (R16—Clinical Trial Not Allowed).                    

*Date:*                         March 21, 2024.                    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21A, Rockville, MD 20852 (Video Assisted Meeting).                    

*Contact Person:*                         Shiv A. Prasad, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21A, Rockville, MD 20852, National Institutes of Health, NIAID, Rockville, MD 20892,                         *shiv.prasad@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: February 16, 2024.

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-03670 Filed 2-22-24; 8:45 am]

BILLING CODE 4140-01-P
Exhibit 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                       AS ADOPTED PURSUANT TO SECTION 906
                                       OF
                         THE SARBANES-OXLEY ACT OF 2002

                  In connection with the quarterly report of I-trax, Inc. (the
"Company") on Form 10-QSB for the period ending September 30, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Frank A. Martin, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:

                  (1) The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

                  (2) The information contained in the Report fairly presents,
in all material respects, the financial condition and result of operations of
the Company.

/s/ Frank A. Martin
-------------------
Frank A. Martin
Chief Executive Officer


December 15, 2004



<PAGE>
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          143852
<SECURITIES>                                         0
<RECEIVABLES>                                  1424411
<ALLOWANCES>                                         0
<INVENTORY>                                     566357
<CURRENT-ASSETS>                               2361583
<PP&E>                                          333254
<DEPRECIATION>                                  120938
<TOTAL-ASSETS>                                 3526338
<CURRENT-LIABILITIES>                          1564452
<BONDS>                                              0
<PREFERRED-MANDATORY>                           810850
<PREFERRED>                                          0
<COMMON>                                         58704
<OTHER-SE>                                     1994071
<TOTAL-LIABILITY-AND-EQUITY>                   3526338
<SALES>                                        9597744
<TOTAL-REVENUES>                               9597744
<CGS>                                          6066427
<TOTAL-COSTS>                                  6066427
<OTHER-EXPENSES>                               3006131
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               23005
<INCOME-PRETAX>                                 512232
<INCOME-TAX>                                    212000
<INCOME-CONTINUING>                             300232
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    300232
<EPS-BASIC>                                        .25
<EPS-DILUTED>                                      .22


</TABLE>
#### Lloyd RAMSEY, Appellant, v. COMMONWEALTH of Kentucky, Appellee.

Court of Appeals of Kentucky.

May 27, 1955.

Rehearing Denied Sept. 30, 1955.

Chat Chancellor, Frankfort, Ben Matthews, Shelbyville, for appellant.

J. D. Buckman, Jr., Atty. Gen., Zeb A. Stewart, Asst. Atty. Gen., for appellee.

PER CURIAM.

The appellant was convicted of the common law offense of wantonly and recklessly wounding another with a pistol without malice, fined $5,000, the maximum amount, and sentenced to six months in jail instead of the maximum of a year in jail. We conclude the instructions given were correct and that an instruction on accidental shooting was properly refused.

The judgment is affirmed.
# C!!ust.er C!!nuuty C!!nmmissinu C!tnuuty nfC!tusttr 1010 

### Main • MILES CITY, MONTANA59301

April13, 2013

Docket Operations M-30 West Building Ground Floor W 12-140 1200 NewJersey Avenue SE Washington, DC 20590; 3 United States ofAmerica Department ofTransportation Office ofSecretary Washington, DC RE: Docket DOS-OST-1997-2605 To Whom It May Concern: Itwould be detrimental both economically and professionally to terminate the EAS for Miles City and Lelll(istown and forthe otherfive cities. The Custer County Commissioners are asking the USDOTto reconsider this termination, to allow Miles City and Lewistown time to resolve this issue oflow ridership. We are confidentthe low ridership issue will be resolved. The low number ofticket sales is a result ofseveral issues: 1. Timing ofthe arrival in Billings makes it difficult for connecting flights to the major airport hubs, causing six to seven hour layovers and sometimes an overnight stay to catch a flightthe next morning. With Miles City and Lewistown being Jess than 150 miles of pavement from Billings, it's efficient use oftime to drive to Billingsjust in time forthe connecting flight. 2. Assertive Marketing would have phone numbers and schedules in the publications in the area. It's rather difficult when the average citizen wants to buy a ticket and doesn't know the name ofthe airline nora schedule.



### TOO 406-874-3457 

### Commissioners 406-874-3350 •406-874-3351 •406-874·33523. Recruiting professionals in the medical field from Denver is easier on the family when a direct flight to Denver is available. 4. Majoremployers in Miles City had been significant users when EAS had good connections. a. Holy Rosary Healthcare, our Medical Center has headquarters in Denver. b. Sanjel USA has their National Headquarters in Denveras well as recruiting riew employees regularly, c. Ft Keogh has their regional offices in Denver. d. OptiBiend, Inc. is a growing and majoremployerwith Headquarters in Texas using· Denver as their majoraccess to Montana. We are asking you to reconsider the termination of Miles City and Lewistown. Let us be part ofthe resolution notthe deterioration in making EAS utilized to the maximum.

Vicki Hamilton Custer County Commissioner Essential AirService Task Force Member 1010 Main Miles City, MT59301 v.hamilton@co.custer.mt.us 406-874-3352

C: Debbie Alke, Department ofTransportation Aeronautics Division, SenatorJon Tester's Office, Senator Max Baucus' Office, Representative Steve Daines' Office
**Exhibit
        32**
 
 
 **CERTIFICATION
        PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED**
 **PURSUANT
        TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**
 
 
 In
        connection with the Annual Report of SpectraScience, Inc. (the “Company”) on
        Form 10-KSB for the periods ended December 31, 2004, 2003, and 2002 as filed
        with the Securities and Exchange Commission on the date hereof (the “Report”),
        the undersigned Chief Executive Officer and Chief Financial Officer of the
        Company hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to
§906 of the Sarbanes-Oxley Act of 2002 that based on his knowledge: 1) the
        Report fully complies with the requirements of Section 13(a) or 15(d) of
        the
        Securities Exchange Act of 1934, and 2) the information contained in the
        Report
        fairly presents, in all material respects, the financial condition and results
        of operations of the Company as of and for the periods covered in the
        Report.
 
 
 /s/
        James
        Hitchin
 
 James
        Hitchin, Chief Executive Officer
 and
        Chief
        Financial Officer
 
 Dated:
        July 6, 2005
 
 
 A
        signed
        original of this written statement required by Section 906, or other document
        authenticating, acknowledging, or otherwise adopting the signature that appears
        in typed form within the electronic version of this written statement required
        by Section 906, has been provided to SpectraScience, Inc. and will be retained
        by SpectraScience, Inc. and furnished to the Securities and Exchange Commission
        or its staff upon request.
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pa ne l una ni m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l a r g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T UN I T E D S T AT E S OF AME R I C A, P l ai nt i ff

- A pp el l ee , v. R I C HA R D A L VA R E Z - AY AL A, D e f

e n d a n t - A p p e lla n t. N o. 12- 50559 D . C . N o . 2 : 1 2 - c r - 0 0 7 0 6 - D MG ME MOR AN DU M *

A pp ea l fr om the U ni t ed S t at es D i stri ctC ou rt f o rth e C e n tr a l D is tr ic t o f C a lif o rn ia D ol l yM . G e e , D i s tr i c tJ udge , P r e s i di ng S ubm i tt e d S e pt e m be r24, 2013 ** B efo re: R A W L IN S O N , N . R . S M IT H , an dC H R IS T E N , C i rcu i tJu d g es. R i c ha r d A l va r e z - A y a l aappe a l s f r om the di s tr i c tc ourt ’ s j udgm e nta nd c ha l l e nge s the 12- m onth a nd one da ys e nt e nc e i m pos e d upon r e voc a t i on of s u p e rv i s e d r e l e a s e . W e h a v e j u r i s d i c t i o n u n d e r2 8 U . S. C. § 1 2 9 1 , a n dw e a f f i rm. A l vare z- A ya l a c on t ends thatthe di stri ctcourterre d w hen i ti m po se d a t erm 

# FI LED OC T 02 2013 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALS12- 50559 2 o f im p r is o n m e n t f

o rth e p u rp o s e o f

r e h ab ilita tio n . W e r e v ie w f o rp la in e rr o r , se e U ni te d State s v . G r ant , 6 6 4 F .3 d 2 7 6 , 2 7 9 ( 9 th C ir . 2 0 1 1 ) , a n df in dn o n e . T he r e c o r dr e f

le c ts th a t th e d is tr ic t c o u rt d is c u s s e dits h o p e th a t A lv a r e z - A y a law o u ld de a l w i th hi s unde r l y i ng s ubs t a nc e abus e pr obl e m s butdi d not“ ‘ i m pos e or l engthen [the cust od i al ] se nt ence t o enabl e [ A l vare z- A ya l a] t o com pl et e a tre atm entprog ram or otherw i se prom ot e r ehabi l i t at i on . ’ ” Se e id . a t281 ( quot i ng T ap i a v. U ni ted States , 13 1 S . C t . 23 82 , 23 92 (201 1)). AF F I RME D.
EXHIBIT
32.1

CERTIFICATION
PURSUANT TO18 U.S.C. SECTION 1350,AS
ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
Section 1350, Chapter 63 of Title 18, United States Code) each of the
undersigned officer(s) of Accelr8 Technology Corporation, a Colorado corporation
(the Corporation), does hereby certify, to such officers
knowledge, that:

The
Annual Report on Form 10-KSB for the year ended July 31, 2006 (the Form
10-KSB) of the Corporation fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
information contained in the Form 10-KSB fairly presents, in all material
respects, the financial condition and results of operations of the Corporation.

Dated:  October
30, 2006

| | /s/     Thomas V. GeimerThomas
V. GeimerChief
Executive Officer and Chief Financial Officer
| | -------------------------------------------------------------------------------------------
EXHIBIT 99
                        CENTURY PARK PICTURES CORPORATION
                           ANNUAL REPORT ON FORM 10KA
                      FOR PERIOD ENDING SEPTEMBER 30, 1999

                             LINGATE FINANCIAL GROUP
                        8301 Golden Valley Road Suite 210
                              Minneapolis, MN 55427
                          612-546-8201 FAX 612.546.1147

                              WITHOUT ATTACHEMENTS

December 9, 1998


Thomas K. Scallen
Century Park Pictures
4701 IDS Center
Minneapolis, MN 55402

Dear Thomas:

I enjoyed meeting with you and Mr. Ron Leckelt to discuss International Theatres
Corporation and its operation of Chanhassen Dinner Theaters. You have asked me
for a market analysis to determine the likely current market value if the
Chanhassen business was to be sold. I have reviewed the financial statements,
budgets, projections, daily cash flow analysis, 10K, 10Qs, and various
statistical reports supplied to me by you as well as historical data I have
obtained from Jean Martinson (controller at Chanhassen Dinner theaters).
Although it would be impractical for me to supply you with the details of my
work in arriving at an opinion, I have nevertheless detailed important
observations and assumptions which I relied upon and I have attached them here
for your review.
It is my opinion that the marketplace would be unwilling to pay any amount for
the stock of International Theatres Corporation if it were to be burdened with
the full $2,064,000 of debt it carried as of the 9-30-98 Fiscal Year End. The
operation has only made a profit once in recent history. It would take
substantial earnings to cover the liabilities, and, further, I have made an
optimistic projection assuming operating income three and one half times as
great as the projected earnings and the company still has no value. I invite you
to review my calculations attached.
On another matter, Ron Leckelt has supplied me with financial statements on a
company known as ":Willy Bietak Productions Inc. Ron has asked me to advise you
whether I thought there would be a market for 30% interest in this company, and
at what value. This company has a negative net worth and lost money last year.
While it is possible that the company possesses intangible values that are not
represented on the financial statements, it seems unlikely that such values
could be significant enough to over come the loss history, negative net worth
and minority discounts associated with the ultimate market value determination.
If you would like me to look into this matter further, please advise.

Sincerely,


Michael P. Hannon
President
#### W. Roshell PERRY, Appellant, v. The STATE of Texas, Appellee.

No. 29436.

Court of Criminal Appeals of Texas.

Jan. 15, 1958.

C. C. Divine, Houston, for appellant.

Dan Walton, Dist. Atty., Thomas D. White, Asst. Dist. Atty., Houston, Leon B. Douglas, State’s Atty., Austin, for the State.

MORRISON, Presiding Judge.

The appellant was convicted in the Corporation Court of the City of Houston for the offense of speeding, appealed such conviction to the County Court at Law No. *2*of Harris County, where he was again convicted and assessed a fine of $25, from which judgment he gave notice of appeal to this Court.

Article 53, Vernon’s Ann.C.C.P., reads, as follows:

> “The Court of Criminal Appeals shall have appellate jurisdiction coextensive with the limits of the State in all criminal cases. This article shall not be so construed as to embrace any case which has been appealed from any inferior court to the county court or county court at law, in which the fine imposed by the county court or county court at law shall not exceed one hundred dollars.”

The appeal is dismissed.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1853 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 1853

 To amend the Immigration and Nationality Act to provide for deferred 
action and parole only in for urgent humanitarian reasons or to gain a 
          significant public benefit, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 11, 2011

 Mr. Poe of Texas introduced the following bill; which was referred to 
                     the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
 To amend the Immigration and Nationality Act to provide for deferred 
action and parole only in for urgent humanitarian reasons or to gain a 
          significant public benefit, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Deferred Action Reform Act of 
2011''.

SEC. 2. DEFERRED ACTION AND PAROLE.

    Section 212(d)(5) of the Immigration and Nationality Act (8 U.S.C. 
1182(d)(5)) is amended by adding at the end the following:
                    ``(C) Notwithstanding any other provision of law, 
                an alien may only be paroled into the United States or 
                granted deferred action of a final order of removal on 
                a case-by-case basis for urgent humanitarian reasons or 
                significant public benefit.''.
                                 <all>
```
Mod_ID MODTYPE

1 Two-Stage

2 Continuous

3 Single-Stage